https://www.biospace.com/press-releases/argenx-to-present-at-upcoming-september-2026-investor-conferences 2026-09-01T08:06:16-04:00 https://www.biospace.com/press-releases/novartis-remibrutinib-a-high-efficacy-oral-btk-inhibitor-significantly-reduces-relapse-rates-and-shows-favorable-safety-profile-in-phase-iii-rms-trials 2026-09-01T08:05:35-04:00 https://www.biospace.com/press-releases/bavarian-nordic-launches-first-tranche-of-new-share-buy-back-program-september-1-2026 2026-09-01T08:07:12-04:00 https://www.biospace.com/press-releases/vicore-pharma-to-participate-in-upcoming-september-2026-healthcare-conferences 2026-09-01T08:07:55-04:00 https://www.biospace.com/press-releases/resolution-therapeutics-partners-with-the-blood-centers-of-america-inc-to-support-broad-patient-access-to-its-experimental-regenerative-macrophage-therapy-in-the-u-s 2026-09-01T08:09:42-04:00 https://www.biospace.com/press-releases/boehringer-ingelheim-launches-scovella-in-great-britain-the-first-approved-therapy-for-insulin-dysregulation-in-horses-a-main-cause-of-laminitis 2026-09-01T08:17:53-04:00 https://www.biospace.com/press-releases/ena-respiratory-awarded-biointelect-venturer-funding-to-support-new-study-in-asthma-patients-of-inna-051-nasal-spray-designed-to-protect-against-symptomatic-viral-respiratory-infections 2026-09-01T08:18:59-04:00 https://www.biospace.com/drug-development/novartis-pauses-car-t-studies-due-to-3-deaths-bms-follows-suit-after-safety-events 2026-09-01T07:54:53-04:00 https://www.biospace.com/policy/9-midsize-drugmakers-climb-aboard-trumps-mfn-train 2026-09-01T08:02:14-04:00